Anavex Life Sciences Corp (AVXL)

[frrol]

Missling's serial endpoint fumbles made him, and the company unfortunately, a lawsuit waiting to happen. The complaint lays out the Rett saga (Avatar and Excellence) pretty well, and includes analyst comments. Re the AD fumbles, we may get some clarity from the research paper on the SAP (specifically, the odds risk gauges) that could head off legal claims. If not, there may be an AD claim filed in the future.

The fumbling seems why the board took away Missling's chairmanship. We did some biostat hiring that would have fixed these problems, but Missling still managed to screw up the Excellence endpoints with CGI mysteriously becoming "primary" again, with no notice or justification (actually contradicting his earlier comments on CGI). Bizarre.

Let's see how the company responds. Aside from our legal response, it would be good to see Missling handing over trial progress and results disclosures to someone more credible and careful.